Clinical Trial Update: Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Tepotinib with Gefitinib in locally advanced or metastatic non-small cell lung cancer (INSIGHT) has completed phases 1 and 2 with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)
• Tepotinib (tepotinib)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-07-23